| Value | ₹1.96 Cr |
|---|
BSE filing, NSE: SYSCHEM. Summary written from the filing by ALFA Finder's alert engine.
Syschem (India) Ltd: key numbers
- Share price
- ₹33.54
- Market cap
- ₹164.4 Cr
- Revenue (annual)
- ₹573.8 Cr
- Net profit (annual)
- ₹10.93 Cr
- P/E (TTM)
- 26.7×Sector 45.9×
- Promoter holding
- 63.38%+3.23% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Syschem (India) Ltd
All →Syschem (India) Results Correction
Syschem India re-submitted its unaudited Q2/H1 FY2026-27 standalone results with the limited review report, following a BSE query. Revenue from operations was Rs 12,979.28 lakh for the quarter, with profit of Rs 191.09 lakh.
Syschem (India) Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹12,979 lakh (+10% YoY), EBITDA ₹466 lakh, PAT ~₹190 lakh after Q1 loss. Turnaround narrative; no explicit guidance.
Syschem (India) Q2 FY27 Results: Net Profit ₹1.9 Cr, Up 0.0% YoY
Syschem (India) Ltd reported revenue from operations of ₹129.8 Cr (+10.1% YoY) and net profit of ₹1.9 Cr (+0.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.9 Cr · +0.0% YoY
Syschem (India) Legal & Regulatory
Syschem (India) Limited has paid a full settlement of ₹1.25 Crore to Lotus Builders. The company is now moving to withdraw pending NCLT litigation.
- Value
- ₹1.25 Cr
Syschem (India) Other Announcement
Syschem (India) Limited reported no deviations in the utilization of funds raised through its preferential issue. As of September 30, 2026, the company utilized Rs. 15.99 Crore.
- Value
- ₹16.00 Cr
Syschem (India) Other Announcement
Syschem India Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This routine disclosure details the current shareholding structure.
Other adverse business impact announcements
All →Medplus Health Services Adverse Business Impact
MedPlus Health Services' subsidiary Optival Health Solutions had its drug licence suspended for five days for a Suryapet store. Expected financial impact is about Rs 1.32 lakh.
- Value
- ₹0.01 Cr
- Execution
- 05 days
Oriental Rail Infrastructure Adverse Business Impact
Oriental Rail's subsidiary Oriental Foundry had a fire at its Kutch plant on 28 October 2026. Damage is minimal, operations are unaffected and the loss is insured.
Capillary Technologies India Adverse Business Impact
Capillary Technologies received KPMG's final forensic report on a cyber-enabled payment fraud at a step-down subsidiary. Four disputed payments totalled EUR 3.04 million, about Rs.32.24 Crore.
- Value
- ₹32.24 Cr
Windlas Biotech Adverse Business Impact
Windlas Biotech disclosed a cyber security incident on 30 October 2026. It states no material impact on core operations, finances or business continuity.
Neogen Chemicals Adverse Business Impact
Neogen Chemicals reports continued fire disruption at MPP3; replacement plant partly built with trial runs underway. Recognized damage totals ₹348.16 crore; production shifted to other sites.
- Value
- ₹348.2 Cr
Hindustan Organic Chemicals Adverse Business Impact
Hindustan Organic Chemicals temporarily shuts down its Kochi Hydrogen plant from 29 October 2026 for pipeline repair and urgent maintenance. Reopening date to be communicated separately.